title: In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.
abstract: Previous pharmacodynamic studies using in vivo candidiasis models have demonstrated that the 24-h area under the concentration-time curve (AUC)/MIC is a good descriptor of the echinocandin exposure-response relationship. Further studies investigating the 24-h AUC/MIC target for a stasis endpoint identified free-drug 24-h AUC/MIC against Candida albicans and were similar for two echinocandins, anidulafungin and micafungin. The current studies expand investigation of a third echinocandin (caspofungin) and compare the pharmacodynamic target among C. albicans, Candida glabrata, and Candida parapsilosis. Treatment studies were conducted with six C. albicans, nine C. glabrata, and 15 C. parapsilosis strains with various MICs (anidulafungin, 0.015 to 4.0 microg/ml; caspofungin, 0.03 to 4.0 microg/ml; and micafungin, 0.008 to 1.0 microg/ml). Efficacy was closely tied to MIC and the 24-h AUC/MIC. Therapy against C. parapsilosis required more of each echinocandin on a mg/kg basis. Caspofungin required less drug on a mg/kg basis for efficacy against all of the organisms than did the other two drugs. However, the 24-h AUC/MIC targets were similar among the echinocandins when free drug concentrations were considered, suggesting the relevance of protein binding. The targets for C. parapsilosis (mean, 7) and C. glabrata (mean, 7) were significantly lower than those for C. albicans (mean, 20) for each echinocandin. The results suggest that current susceptibility breakpoints and the consideration of organism species in these determinations should be reexplored.
authors.affiliation: Department of Medicine and Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, WI 53792, USA. dra@medicine.wisc.edu
authors.forename: D
authors.initials: D
authors.lastname: Andes
authors.forename: D J
authors.initials: DJ
authors.lastname: Diekema
authors.forename: M A
authors.initials: MA
authors.lastname: Pfaller
authors.forename: J
authors.initials: J
authors.lastname: Bohrmuller
authors.forename: K
authors.initials: K
authors.lastname: Marchillo
authors.forename: A
authors.initials: A
authors.lastname: Lepak
mesh_terms: D000077612:Anidulafungin; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects*; D002176:Candida albicans / Q000187:drug effects; D041221:Candida glabrata / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy* / Q000378:metabolism / Q000382:microbiology; D000077336:Caspofungin; D054714:Echinocandins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D005260:Female; D007668:Kidney / Q000382:microbiology; D055666:Lipopeptides / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D000077551:Micafungin; D051379:Mice; D008813:Mice, Inbred ICR; D008826:Microbial Sensitivity Tests; D011485:Protein Binding; D013045:Species Specificity
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077612:Anidulafungin; D000077336:Caspofungin; D000077551:Micafungin
references.citation: Pharmacotherapy. 2006 Jun;26(6):877-80
references.pmid: 16716141
references.citation: Clin Infect Dis. 2009 Mar 1;48(5):503-35
references.pmid: 19191635
references.citation: Antimicrob Agents Chemother. 2007 Nov;51(11):4214-6
references.pmid: 17785512
references.citation: Infection. 2002 Oct;30(5):286-91
references.pmid: 12382088
references.citation: Antimicrob Agents Chemother. 2003 Dec;47(12):3935-41
references.pmid: 14638504
references.citation: Mycoses. 2009 Nov;52(6):493-8
references.pmid: 19207835
references.citation: Antimicrob Agents Chemother. 2003 Apr;47(4):1187-92
references.pmid: 12654645
references.citation: Antimicrob Agents Chemother. 2006 Jul;50(7):2522-4
references.pmid: 16801435
references.citation: J Clin Microbiol. 2008 Aug;46(8):2659-64
references.pmid: 18562582
references.citation: N Engl J Med. 2007 Jun 14;356(24):2472-82
references.pmid: 17568028
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3165-9
references.pmid: 14506026
references.citation: Antimicrob Agents Chemother. 2002 Jun;46(6):1665-70
references.pmid: 12019073
references.citation: J Clin Microbiol. 2005 Nov;43(11):5425-7
references.pmid: 16272464
references.citation: Antimicrob Agents Chemother. 2008 Feb;52(2):539-50
references.pmid: 18070979
references.citation: J Antimicrob Chemother. 2006 Apr;57(4):705-8
references.pmid: 16464893
references.citation: Antimicrob Agents Chemother. 2007 Jun;51(6):2253-6
references.pmid: 17420211
references.citation: Lancet. 2007 May 5;369(9572):1519-1527
references.pmid: 17482982
references.citation: J Clin Microbiol. 2006 Mar;44(3):819-26
references.pmid: 16517860
references.citation: Antimicrob Agents Chemother. 2007 Mar;51(3):968-74
references.pmid: 17194830
references.citation: N Engl J Med. 2002 Dec 19;347(25):2020-9
references.pmid: 12490683
references.citation: J Clin Microbiol. 2008 Mar;46(3):842-9
references.pmid: 18199791
references.citation: Clin Infect Dis. 2006 Apr 1;42(7):938-44
references.pmid: 16511756
references.citation: Antimicrob Agents Chemother. 2006 Sep;50(9):3160-1
references.pmid: 16940118
references.citation: J Clin Microbiol. 2006 Mar;44(3):760-3
references.pmid: 16517851
references.citation: Curr Opin Infect Dis. 2001 Apr;14(2):165-72
references.pmid: 11979128
references.citation: Clin Infect Dis. 2007 Jan 1;44(1):79-86
references.pmid: 17143821
references.citation: Haematologica. 2008 Apr;93(4):639-40
references.pmid: 18379015
references.citation: Antimicrob Agents Chemother. 2004 Apr;48(4):1382-3
references.pmid: 15047549
references.citation: Antimicrob Agents Chemother. 2005 Dec;49(12):5058-68
references.pmid: 16304173
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3149-54
references.pmid: 14506023
references.citation: Diagn Microbiol Infect Dis. 2008 Mar;60(3):329-31
references.pmid: 18024052
references.citation: Clin Infect Dis. 1997 Feb;24(2):235-47
references.pmid: 9114154
references.citation: Antimicrob Agents Chemother. 2006 Nov;50(11):3695-700
references.pmid: 16954319
references.citation: Clin Infect Dis. 2006 Jul 15;43(2):215-22
references.pmid: 16779750
references.citation: J Clin Microbiol. 2006 Oct;44(10):3533-8
references.pmid: 17021079
references.citation: J Clin Pharmacol. 2005 Oct;45(10):1145-52
references.pmid: 16172179
references.citation: J Clin Microbiol. 2008 Jan;46(1):150-6
references.pmid: 18032613
references.citation: Clin Infect Dis. 2006 Apr 15;42(8):1171-8
references.pmid: 16575738
references.citation: Antimicrob Agents Chemother. 2005 Aug;49(8):3264-73
references.pmid: 16048935
references.citation: Antimicrob Agents Chemother. 2003 Apr;47(4):1179-86
references.pmid: 12654644
references.citation: Antimicrob Agents Chemother. 1997 Nov;41(11):2339-44
references.pmid: 9371330
references.citation: Antimicrob Agents Chemother. 2004 Jan;48(1):137-42
references.pmid: 14693531
references.citation: Clin Infect Dis. 2007 Oct 1;45(7):883-93
references.pmid: 17806055
references.citation: Antimicrob Agents Chemother. 2005 Sep;49(9):3616-23
references.pmid: 16127030
references.citation: J Infect Dis. 2004 Oct 15;190(8):1464-71
references.pmid: 15378439
references.citation: Antimicrob Agents Chemother. 2008 Oct;52(10):3497-503
references.pmid: 18625768
references.citation: J Infect. 2008 Feb;56(2):126-9
references.pmid: 18082269
references.citation: Antimicrob Agents Chemother. 2003 Apr;47(4):1193-9
references.pmid: 12654646
references.citation: Clin Infect Dis. 1998 Jan;26(1):1-10; quiz 11-2
references.pmid: 9455502
references.citation: Clin Infect Dis. 2003 Sep 1;37(5):634-43
references.pmid: 12942393
references.citation: Antimicrob Agents Chemother. 2008 Nov;52(11):4181-3
references.pmid: 18794386
references.citation: Methods Mol Med. 2005;118:111-28
references.pmid: 15888938
references.citation: Antimicrob Agents Chemother. 2009 Jan;53(1):112-22
references.pmid: 18955538
references.citation: Int J Antimicrob Agents. 2002 Apr;19(4):261-8
references.pmid: 11978497
references.citation: J Clin Microbiol. 2008 Aug;46(8):2620-9
references.pmid: 18579718